Literature DB >> 16528544

Daily urinary interleukin-11 excretion correlated with proteinuria in IgA nephropathy and lupus nephritis.

Jien-Wen Chien1, Woan-Ling Chen, Yi-Giien Tsui, Min-Chun Lee, An-Yi Lin, Ching-Yuang Lin.   

Abstract

Interleukin-11 (IL-11) is a multifunctional cytokine with both thrombopoietic and anti-inflammatory effects. In an animal study IL-11 was shown to reduce proteinuria in mice with necrotizing glomerulonephritis. The purpose of this current study is to explore the role of IL-11 in human glomerulonephritis. Subjects of this study were patients with proteinuria (daily urine protein excretion >40 mg/m2 per hour) and underlying pathology of IgA nephropathy (IgAN) (n=20), lupus nephritis (LN) (n=40), and idiopathic nephrotic syndrome (INS) (n=68). Daily urinary IL-11 level was measured by enzyme-linked immunosorbent assay (ELISA). Correlation between urinary IL-11 and urinary protein was determined by Pearson's correlation coefficient. Another five patients with serial data of urinary protein, IL-11 and IL-11 messenger RNA (mRNA) expression in urine sediment are presented. The correlation between urinary IL-11 and daily urinary protein was significant for patients with IgAN (r=0.596, P=0.006) and LN (r=0.630, P<0.001), but not for patients with INS (r=0.030, P=0.812). Serial data revealed the same correlation. Furthermore, the peak of urinary IL-11 mRNA preceded that of urinary IL-11. We conclude that daily urinary IL-11 excretion is correlated with urinary protein loss in nephritis having local T helper (Th)1 predominant immune response, such as IgAN and LN. Local IL-11 production may serve as a counter cytokine against Th1-mediated inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16528544     DOI: 10.1007/s00467-006-0016-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  32 in total

1.  Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis.

Authors:  S R Holdsworth; A R Kitching; P G Tipping
Journal:  Kidney Int       Date:  1999-04       Impact factor: 10.612

2.  Histochemical demonstration of the in vivo localization of antibodies: antigenic components of the kidney and the pathogenesis of glomerulonephritis.

Authors:  R C MELLORS
Journal:  J Histochem Cytochem       Date:  1955-07       Impact factor: 2.479

3.  Pharmacokinetics of recombinant human interleukin-11 (rhIL-11) in healthy male subjects.

Authors:  K Aoyama; T Uchida; F Takanuki; T Usui; T Watanabe; S Higuchi; T Toyoki; H Mizoguchi
Journal:  Br J Clin Pharmacol       Date:  1997-06       Impact factor: 4.335

Review 4.  IL-11: insights in asthma from overexpression transgenic modeling.

Authors:  T Zheng; Z Zhu; J Wang; R J Homer; J A Elias
Journal:  J Allergy Clin Immunol       Date:  2001-10       Impact factor: 10.793

5.  Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kappaB in proximal tubule cells.

Authors:  Y Wang; G K Rangan; Y C Tay; Y Wang; D C Harris
Journal:  J Am Soc Nephrol       Date:  1999-06       Impact factor: 10.121

6.  Correlation between anti-Ro/La titers and clinical findings of patients with systemic lupus erythematosus.

Authors:  J W Chien; C Y Lin; L Y Yang
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  2001-05

Review 7.  Hematopoietic, immunomodulatory and epithelial effects of interleukin-11.

Authors:  U S Schwertschlag; W L Trepicchio; K H Dykstra; J C Keith; K J Turner; A J Dorner
Journal:  Leukemia       Date:  1999-09       Impact factor: 11.528

8.  Hematuria and proteinuria in a mass school urine screening test.

Authors:  Yong-Hoon Park; Jung-Youn Choi; Hyo-Seok Chung; Ja-Wook Koo; Su-Yung Kim; Mee-Kyung Namgoong; Young-Seo Park; Kee-Hwan Yoo; Kyung-Yil Lee; Dae-Yeol Lee; Seung-Joo Lee; Ji-Eun Lee; Woo-Yeong Chung; Tae-Sun Hah; Hae-Il Cheong; Yong Choi; Kyung-Soo Lee
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

9.  Clinicopathological study of the WHO classification in childhood lupus nephritis.

Authors:  Michael Zappitelli; Ciaran Duffy; Chantal Bernard; Rosie Scuccimarri; Karen Watanabe Duffy; Rhoda Kagan; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2004-03-12       Impact factor: 3.714

10.  Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis.

Authors:  L Moreland; R Gugliotti; K King; W Chase; M Weisman; T Greco; R Fife; J Korn; R Simms; J Tesser; J Hillson; J Caldwell; T Schnitzer; D Lyons; U Schwertschlag
Journal:  Arthritis Res       Date:  2001-04-10
View more
  6 in total

1.  Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis.

Authors:  Michael Zappitelli; Ciarán M Duffy; Chantal Bernard; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2007-10-24       Impact factor: 3.714

2.  Imbalance towards Th1 pathway predominance in purpura nephritis with proteinuria.

Authors:  Kazushi Tsuruga; Shojiro Watanabe; Eishin Oki; Tomomi Aizawa-Yashiro; Hidemi Yoshida; Tadaatsu Imaizumi; Etsuro Ito; Hiroshi Tanaka
Journal:  Pediatr Nephrol       Date:  2011-09-16       Impact factor: 3.714

3.  A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome.

Authors:  Anissa A Widjaja; Shamini G Shekeran; Eleonora Adami; Joyce G Wei Ting; Jessie Tan; Sivakumar Viswanathan; Sze Yun Lim; Puay Hoon Tan; Norbert Hübner; Thomas Coffman; Stuart A Cook
Journal:  J Am Soc Nephrol       Date:  2022-02-09       Impact factor: 14.978

4.  Expression of mRNA for functional molecules in urinary sediment in glomerulonephritis.

Authors:  Koji Tsugawa; Eishin Oki; Koichi Suzuki; Tadaatsu Imaizumi; Etsuro Ito; Hiroshi Tanaka
Journal:  Pediatr Nephrol       Date:  2007-12-19       Impact factor: 3.714

Review 5.  IL-11 in cardiac and renal fibrosis: Late to the party but a central player.

Authors:  Benjamin Corden; Eleonora Adami; Mark Sweeney; Sebastian Schafer; Stuart A Cook
Journal:  Br J Pharmacol       Date:  2020-02-22       Impact factor: 8.739

6.  Urinary Sediment mRNA Level of CREBBP and CYBA in Children With Steroid-Resistant Nephrotic Syndrome.

Authors:  Wei Li; Xinyi Shou; Wenqing Xiang; Lin He; Lin Li; Haidong Fu; Jianhua Mao
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.